Jonathan Kwok, Chief Executive Officer & Co-Founder at Infinitopes, said: Using our integrated 'right targets, right vectors, right patients, right time' approach, we aim to address the unmet clinical ...

Elizabeth Eilertsen explains how she opened a practice that aims to put patients at ease and puts their needs first.

Infinitopes' lead vaccine candidate ITOP1 is a novel, precision targeted, immunologically durable, "off-the-shelf" cancer vaccine, designed to save lives by preventing disease recurrence in first-line ...

Preclinical proof-of-concept data supports the potential of CD3 Switch-DARPin platform to activate and boost T cells in the presence of tumor ...

Lip problems, simply, have been impossible to treat. Dr. Martin Egen at Bern University Hospital "just changed that." ...

Regulating drug discovery and pharmaceutical manufacturing, the FDA ensures the safety and effectiveness of innovative ...

According to a new study, cases of babesiosis rose by an average of 9% annually between 2015 and 2022, with nearly half of the affected individuals also co-infected with another tick-borne illness, ...

Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced upcoming presentations of six posters highlighting data from their ...

Prostate cancer is the second most common cancer in men worldwide. Despite medical advances in recent years, this type of ...

Boston Children's Hospital and Harvard Medical School researchers have discovered a neuroimmune communication pathway that ...

MindMed is poised for significant developments with MM-120 in upcoming trials. Discover why monitoring MNMD stock is ...